9 Ways to Manage Dyskinesia in Advanced Parkinson’s Disease

1. Talk to Your Doctor About Changing Your Medication Dosage
Tweaking your dosage of levodopa or other dopaminergic medications (drugs that affect the dopamine-producing parts of the brain) can often help improve dyskinesias.
2. Tweak the Timing of Your Medication
3. Start or Stop Taking Other Medications for Your Parkinson’s Disease
- An antiviral and antidyskinetic medication called amantadine (Gocovri, Symmetrel) may be prescribed to help reduce dyskinesias without worsening “off” periods.
- An extended-release formulation of amantadine (Gocovri) is used specifically for the treatment of levodopa-induced dyskinesia in people with Parkinson’s disease.
- Other amantadine formulations are also sometimes used off-label for dyskinesia.
4. Ask Your Doctor About Continuous Drug Delivery
One way to potentially avoid fluctuations in medication delivery and dopamine levels (and potentially reduce dyskinesias) is through a continuous drug delivery system such as Duopa.
5. Consider Deep Brain Stimulation
“Deep brain surgery has the greatest promise on an individual level,” says Pantelyat. But there are also risks. “Depending on the experience of the surgeon,” he says, “there’s a risk of bleeding or trauma to the brain, as well as a slight hit to verbal memory — for example, the ability to remember names of animals or words starting with the letter ‘f’ may be impaired for a while. Usually it’s a short-term problem, but in some people it can be a long-term one.”
6. Adjust Your Diet
No specific diet helps treat dyskinesia, but there are dietary changes you can make that can affect how your body absorbs and uses levodopa.
That’s a problem because it may mean taking a higher dose to get the same effect — and a higher dose means a higher risk of dyskinesia.
7. Lower Your Stress
8. Find New Ways to Exercise
9. Get Enough Sleep
- Parkinson’s Disease. Mayo Clinic. September 27, 2024.
- Dyskinesia. Parkinson’s Foundation.
- Dyskinesia in Parkinson’s Disease. The Michael J. Fox Foundation for Parkinson’s Research.
- He T et al. Dose–Response Relationship of Levodopa With Dyskinesia in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Heliyon. March 30, 2024.
- Chase TN et al. Reduced Plasma Levodopa Fluctuations With More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet. Clinical Pharmacology in Drug Development. January 4, 2024.
- Lees A et al. Optimizing Levodopa Therapy, When and How? Perspectives on the Importance of Delivery and the Potential for an Early Combination Approach. Expert Review of Neurotherapeutics. February 2, 2023.
- Duopa. Parkinson’s Foundation.
- U.S. FDA Approves VYALEV (Foscarbidopa and Foslevodopa) for Adults Living With Advanced Parkinson's Disease . PR Newswire. October 17, 2024.
- Common Questions About Vyalev Treatment for Parkinson’s. The Michael J. Fox Foundation for Parkinson’s Research. January 26, 2026.
- Katzenschlager R et al. Continuous Subcutaneous Infusion Therapies in Parkinson’s Disease: Evidence of Efficacy and Safety. Parkinsonism & Related Disorders. September 30, 2025.
- Deep Brain Stimulation (DBS). Parkinson’s Foundation.
- Rusch C et al. To Restrict or Not to Restrict? Practical Considerations for Optimizing Dietary Protein Interactions on Levodopa Absorption in Parkinson’s Disease. NPJ Parkinson’s Disease. June 24, 2023.
- Eating Well With Parkinson’s: Diet and Nutrition Tips. The Michael J. Fox Foundation for Parkinson’s Research.
- Van Der Heide A et al. Stress and Mindfulness in Parkinson's Disease — a Survey in 5,000 Patients. NPJ Parkinson’s Disease. January 18, 2021.
- Speck AE. Relationship between physical exercise and the most varied forms of dyskinesia. The Journal of Physical Education. April 2021.
- Van Der Heide A et al. Stress and Mindfulness in Parkinson’s Disease — a Survey in 5,000 Patients. NPJ Parkinson’s Disease. January 18, 2021.
- Parkinson’s Disease: Exercising Through the Stages. Hackensack Meridian Health. April 24, 2025.
- Physical Activity and Advanced Parkinson’s. Parkinson’s UK. April 24, 2025.
- Parkinson’s Disease and Dyskinesia. American Parkinson Disease Association.
- Sleep Problems. American Parkinson Disease Association.

Sneha Mantri, MD, MS
Medical Reviewer
As the Parkinson’s Foundation first-ever chief medical officer, Sneha Mantri, MD, MS, leads medical and clinical care efforts, guiding the Foundation’s care portfolio and strategy ...
Natalie Gingerich Mackenzie
Author
Natalie Gingerich Mackenzie is a freelance writer and editor specializing in health and fitness. A former editor at SELF and Prevention magazines, she has also written for Shape, M...